Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro
- 105 Downloads
It was evident that nitrosamines can act directly on target tissue and result in carcinogenesis. As has been shown, the carcinogenic activity of nitrosamines relied on its bioactivation by Cytochrome P450 2E1 (CYP2E1). In this study, we investigated the expression of CYP2E1 in Nasopharyngeal carcinoma (NPC) cells, embryonic nasopharyngeal epithelial tissue (ENET) specimens, and NPC biopsies by RT-PCR analysis. CYP2E1 was expressed in all NPC cell lines (6/6, including 7429) and ENET (6/6), and 80% of NPC biopsie (8/10). The fact that Human nasopharynx expresses CYP2E1 suggests that CYP2E1 may play an important role in the course of NPC by indirect carcinogens nitrosamines. To further evaluate the function of CYP2E1, the CYP2E1 was stably expressed in the cell line NIH 3T3/rtTA under a tetracycline-controlled transactivator. The expression of CYP2E1 was tightly regulated in a dose-dependent manner by Doxycycline (Dox) When the catalytic activity of CYP2E1 was assayed, the result showed that the generation of 6-hydroxychlorzoxazone (6-OH-CZ) from chlorzoxazone (CZ) was dose- and time-dependent on Dox addition to the medium. In the presence of 1 µg/ml Dox, the CZ 6-hydroxylase activity of the cell line was found to be 0.986 ± 0.034 nmol/106 cells/h. The metabolic activation of Tet/3T3/2E1-6 cells was also assayed by N,N′-dinitrosopiperazine (DNP) cytotoxicity, and the viability of Tet/3T3/2E1-6 cells treated with Dox was lower than that of untreated cells with a significant difference between them in 80 and 160 µg/ml DNP (P ( 0.05, t test. This cell line will be useful not only to assess the metabolic characteristics of CYP2E1, but also will be useful to investigate the role of CYP2E1 in metabolic activation of carcinogenic nitrosamines in vitro.
KeywordsCYP2E1 NPC Tetracycline-controlled expression system Metabolic activation
High Performance Liquid Chromatography
Unable to display preview. Download preview PDF.
This work was supported by Grant 39570623 from National Natural Science Foundation of China.
- 1.Yu MC, Henderson BE (1996) Nasopharyngeal cancer. In Schottenfeld D, Fraumeni JF (Eds), Cancer epidemiology and prevention, 2nd edn. Oxford University Press: New York, pp 603–618Google Scholar
- 10.He ZM, Yuan JH, Wang SL, Lai JP, Tu QS, Chen ZC (1999) Association of between genetic polymorphism of human cytochrome P450 2E1 gene and susceptibility to nasopharyngeal carcinoma. Chin J Cancer 18:517–519Google Scholar
- 11.Kongruttanachok N, Sukdikul S, Setavarin S, Kerekhjanarong V, Supiyaphun P, Voravud N, Poovorawan Y, Mutirangura A (2001) Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 1: 4. Epub 2001Google Scholar
- 14.Godoy W, Albano RM, Moraes EG, Pinho PR, Nunes RA, Saito EH, Higa C, Filho IM, Kruel CD, Schirmer CC, Gurski R, Lang MA, Pinto LF (2002) CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 23:611–616PubMedCrossRefGoogle Scholar
- 21.The Cancer Research Group of Medical College (1978) Inducetion of nasopharyngeal carcinoma in rats by nitrosocompounds. Kexue Tongbao (chinese) 23:756–769Google Scholar
- 29.Diane JLM, Yvonne AB, Christopher RB (2004) DNA damage and cytotoxicity in pancreatic b-cells expressing human CYP2E1. Biochem Pharmacol 68:523–530Google Scholar